
Soxime CV 50mg/31.25mg Dry Syrup
Marketer
Yester Pharma Pvt Ltd
Salt Composition
Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg)
Overview Soxime CV 50mg/31.25mg Dry Syrup
Pediax Duo 50mg/31.25mg oral suspension is a powerful combination antibiotic formulated for pediatric use. It combats various serious bacterial infections affecting the ears, throat, lungs, skin, and urinary system in children. Its mechanism involves halting bacterial proliferation, thus controlling infection. Administer this medication to your child one hour before or two hours after meals; however, if stomach upset occurs, give it with food. Always adhere to the prescribed dosage, as it's tailored to your child's specific infection, its severity, and their age and weight. Should your child vomit the medicine within 30 minutes of ingestion, repeat the dose; avoid doubling the dose if it's near the next scheduled time. Minor, temporary side effects may include vomiting, diarrhea, nausea, rash, or headache, generally resolving as your child adjusts. Persistent or troubling side effects warrant immediate medical attention. Fully disclose your child's medical history to their physician, including any prior allergies, heart conditions, blood disorders, congenital defects, respiratory issues, lung abnormalities, digestive problems, skin conditions, liver impairment, or kidney dysfunction. This information is crucial for accurate dosing and comprehensive treatment planning.
Uses of Soxime CV 50mg/31.25mg Dry Syrup
Managing respiratory system infections
Major Benefits of Soxime CV 50mg/31.25mg Dry Syrup:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Consult the product label for complete instructions prior to consumption. Dissolve the powder completely in sterile water; shake vigorously before use. Soxime CV 50mg/31.25mg Dry Syrup can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Soxime CV 50mg/31.25mg Dry Syrup:
- Nausea
- Diarrhea
- Headache
- Rash
- Abdominal pain
- Vaginal infection
- Fungal infection of vagina
How to use Soxime CV 50mg/31.25mg Dry Syrup:
Administer this medication precisely as prescribed by your physician, adhering to the dosage and treatment schedule. Always consult the product label for complete instructions prior to use. Dissolve the powder in sterile water; shake thoroughly before consumption. Soxime CV 50mg/31.25mg Dry Syrup can be ingested with or without food, however, consistent timing is recommended.
How Soxime CV 50mg/31.25mg Dry Syrup works:
Soxime CV Dry Syrup, containing 50mg Cefpodoxime Proxetil and 31.25mg Clavulanic Acid, combines an antibiotic with a beta-lactamase inhibitor. Cefpodoxime Proxetil's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Clavulanic Acid counters bacterial resistance mechanisms, thereby boosting Cefpodoxime Proxetil's effectiveness.
SAFETY ADVICE
KidneySAFE IF PRESCRIBED
Soxime CV 50mg/31.25mg Dry Syrup poses no safety concerns for individuals with kidney impairment; dose alteration is generally unnecessary. Nevertheless, children experiencing severe kidney disease may need adjusted dosages. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Soxime CV 50mg/31.25mg Dry Syrup poses no known risk requiring dose modification in individuals with liver impairment. Nevertheless, parental consultation with a physician is advised prior to administering Soxime CV 50mg/31.25mg Dry Syrup to children exhibiting severe hepatic dysfunction.
What if you forget to take Soxime CV 50mg/31.25mg Dry Syrup :
Remain calm. Unless otherwise directed by your child's physician, administer the forgotten dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Adhere to the recommended dosage schedule; avoid doubling the dose to compensate for a missed one.
Facts to Know About Soxime CV 50mg/31.25mg Dry Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
